BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
Rhea-AI Summary
BiomX (NYSE:PHGE) completed the acquisition of 100% of Zorronet from Water.io on April 10, 2026, entering the defense, rescue and security sector.
Zorronet supplies AI command-and-control software integrating video analytics, drones, sensors and IoT, with contracts including the Israel Defense Forces and Israel Railways. BiomX says the move complements its option to acquire DFSL and targets a combined ~$81B command-and-control and video analytics market by 2030.
Positive
- Acquired 100% of Zorronet on April 10, 2026
- Targets combined market of ~$81B by 2030
- Zorronet has contracts with Israel Defense Forces and Israel Railways
- Complementary option to acquire DFSL (LADAR, C-UAS capabilities)
Negative
- Purchase price and transaction financial terms were not disclosed
News Market Reaction – PHGE
On the day this news was published, PHGE declined 3.34%, reflecting a moderate negative market reaction. Argus tracked a trough of -18.4% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $676K from the company's valuation, bringing the market cap to $19.57M at that time. Trading volume was above average at 1.6x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Among tracked peers, BIVI was up about 5.56%, while APLM and IMRN were down roughly 3.89% and 3.39%, respectively. Sector scanners flagged broader biotech dynamics, but moves were mixed across names.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 31 | Defense acquisition option | Positive | -16.4% | Option to acquire DFSL LADAR counter-drone platform for defense markets. |
| Mar 30 | Advisory board change | Positive | -2.8% | Added former Mossad deputy to guide security and defense expansion. |
| Mar 27 | Listing deficiency notice | Negative | -2.8% | NYSE American notice on stockholders’ equity deficiency and going concern. |
| Mar 26 | Security subsidiary launch | Positive | -3.7% | Launched X Security & Defense and committed over $3M from internal funds. |
| Mar 19 | CEO strategic reset | Neutral | -1.2% | CEO outlined financial reset, warrant amendments, and defense repositioning. |
Recent strategic and defense-focused announcements have often coincided with negative next-day moves, even when operationally positive, while regulatory/deficiency news has also seen modest declines.
Over the past month, BiomX announced multiple steps in a strategic pivot toward defense and security. On Mar 19, 2026, a CEO letter outlined a reset and warrant amendments (24h move -1.19%). On Mar 26, it launched X Security & Defense and committed over $3 million to 2026 operations (24h move -3.68%). A NYSE American equity deficiency notice on Mar 27 brought listing risk (24h move -2.81%). An advisory board addition on Mar 30 and a LADAR-focused acquisition option on Mar 31 further advanced the pivot, yet drew 24h moves of -2.81% and -16.39%, respectively. Today’s Zorronet deal builds directly on this defense-focused strategy.
Regulatory & Risk Context
An effective S-3 filed on Feb 9, 2026 registers up to 5,310,933 common shares for resale tied to Series Y preferred conversions, warrant exercises and dividend shares. As of Feb 3, 2026 there were 1,593,516 shares outstanding, so full issuance would significantly increase the share count and dilute existing holders. The registered securities stem from a private placement carrying a 15% annual dividend and related warrants, which together introduce ongoing overhang and covenant constraints around new financings.
Market Pulse Summary
This announcement adds a concrete AI command-and-control asset, Zorronet, to BiomX’s emerging defense and security strategy, complementing the DFSL option and the newly formed X Security & Defense subsidiary. The deal targets large markets, with command and control projected at $44 billion and video analytics above $37 billion by 2030. Against this opportunity, investors must weigh NYSE American equity deficiency disclosures and potential dilution from up to 5,310,933 registered resale shares when assessing how this acquisition fits into the broader reset.
Key Terms
command-and-control technical
video analytics technical
iot devices technical
ladar technical
c-uas technical
situational awareness technical
tier-1 oems technical
ai-powered technical
AI-generated analysis. Not financial advice.
Targets
NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that it has completed the acquisition of
Zorronet is a developer of AI-powered command-and-control software that uses artificial intelligence and machine learning to integrate video analytics, drones, sensors, and IoT devices into a unified operational intelligence environment. Its software ingests and analyzes multiple data and sensor streams simultaneously to detect, classify, and prioritize potential threats in near real time, enabling more efficient decision-making through a unified and actionable intelligence layer.
Zorronet has contracts with the Israel Defense Forces as well as major critical infrastructure including Israel Railways. The company also serves government customers, Tier-1 OEMs such as Elbit Systems, and international clients. Its platform is deployed in mission-critical defense and security environments where real-time situational awareness and rapid response are essential.
The acquisition complements the Company’s previously announced option to acquire control of DFSL, an Israeli LADAR (Laser Detection and Ranging) solutions company with established capabilities in counter-unmanned aerial systems (C-UAS), perimeter and border security, and advanced detection technologies. Both companies have demonstrated their technologies in real-world operational environments, including deployments supporting critical infrastructure and national border defense.
Modern security and defense operations rely on a growing network of sensors and connected systems that continuously generate large volumes of data. Operators often rely on multiple disconnected systems, increasing response times and the risk of missed threats. Zorronet addresses this challenge by bringing together fragmented systems into a unified environment, where data from cameras, drones, sensors, and IoT devices is continuously analyzed and translated into actionable intelligence, enabling operators to move from passive monitoring to active threat management and supporting enhanced monitoring and response capabilities.
These trends are reflected in broader market growth, with the global command and control systems market projected to reach approximately
“The acquisition of Zorronet strengthens our ability to support real-time decision-making across complex security environments,” said Michael Oster, Chief Executive Officer of BiomX. “As the volume of data generated by sensors, drones, and connected systems continues to grow, the ability to interpret that data efficiently and respond in a timely manner becomes increasingly important. This acquisition marks an important step in our entry into the defense sector and our focus on acquiring and building a diversified portfolio across defense, rescue, and security sectors.”
Additional details are available in the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” “should,” “anticipates,” “potential,” “continue,” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the expected benefits of the acquisition, the Company’s strategic direction, and the expansion of its capabilities in defense, security, and critical infrastructure markets. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied. These risks and uncertainties are described more fully in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update these statements, except as required by law.
Contact Michael Oster info@biomx.com